Document Detail


Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
MedLine Citation:
PMID:  20735385     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVE: • To study the effects of montelukast (ML), a leukotriene receptor antagonist which has been shown to be effective in inhibiting the action of cysteinyl-containing leukotrienes, on protamine sulphate (PS)-induced changes in rat urinary bladder.
MATERIALS AND METHODS: • Wistar female rats were catheterized and intravesically infused with PBS (control group) or PS (PS group) dissolved in PBS twice in 24 h. • In the PS-applied and ML-treated group (PS + ML group) after the 10 mg/kg PS instillation, ML was injected i.p. twice daily for 3 days. • The urinary bladder was investigated for general morphology under a light microscope. • Tryptase immunohistochemistry was used to observe mast cell distribution and activation. Uroplakin distribution was also identified with immunohistochemistry.
RESULTS: • Alterations of glycosaminoglycan (GAG) and urothelial permeability were seen with ruthenium red (RR) staining techniques under a transmission electron microscope, and topographical changes of luminal urothelial structure were seen with a scanning electron microscope. • Biochemically malondialdehyde (MDA) and gluthatione (GSH) concentrations were analysed. In the PS group, there was degenerated urothelium with irregular uroplakin distribution, increased inflammatory cell infiltration, increased number of both granulated and activated mast cells, irregularity of GAG and penetration of RR into the intercellular spaces and dilated tight junctions. • In PS + ML group, there was relatively regular uroplakin distribution, a decrease in inflammatory cell infiltration, a decreased number of both activated and granulated mast cells in the mucosa, regular GAG and no penetration of RR into the intercellular areas, and regular tight junctions in most regions. • The significant decrease in MDA and the increased GSH concentrations in the PS + ML group was in accordance with the histological findings.
CONCLUSION: • Montelukast appears to have a protective function in the bladder injury model via the anti-inflammatory effects of this leukotriene receptor antagonist.
Authors:
Sule Çetinel; Yasemin Ersoy Çanıllıoğlu; Esra Çikler; Göksel Sener; Feriha Ercan
Related Documents :
6722535 - Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat.
22449795 - Kinetic effects of carbon monoxide inhalation on tissue protection in ventilator-induce...
18082195 - Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
1647505 - Acrylamide-induced visceral neuropathy: evidence for the involvement of capsaicin-sensi...
6670055 - Changes of lipid peroxidation in mouse brain crude synaptosomal preparations in relatio...
7237125 - Changes of electroretinogram and neurochemical aspects of gabaergic neurons of retina a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  BJU international     Volume:  107     ISSN:  1464-410X     ISO Abbreviation:  BJU Int.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-09-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100886721     Medline TA:  BJU Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  1320-5     Citation Subset:  IM    
Affiliation:
Department of Histology and Embryology, School of Medicine, Marmara University, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical ...
Next Document:  Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening coh...